Capitolis Liquid Global Markets LLC Takes Position in Globe Life Inc. $GL

Capitolis Liquid Global Markets LLC acquired a new position in Globe Life Inc. (NYSE:GL) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 41,000 shares of the company’s stock, valued at approximately $5,862,000. Capitolis Liquid Global Markets LLC owned about 0.05% of Globe Life at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in GL. Allianz Asset Management GmbH lifted its position in shares of Globe Life by 55.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after acquiring an additional 29,256 shares during the last quarter. Synergy Asset Management LLC grew its holdings in shares of Globe Life by 1,022.7% in the 3rd quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock worth $14,240,000 after acquiring an additional 91,642 shares during the last quarter. Retirement Systems of Alabama acquired a new position in shares of Globe Life in the 3rd quarter worth $2,470,000. SteelPeak Wealth LLC acquired a new stake in shares of Globe Life during the third quarter worth $2,985,000. Finally, Pzena Investment Management LLC lifted its holdings in shares of Globe Life by 5.6% during the third quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock valued at $142,756,000 after purchasing an additional 52,523 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Down 0.2%

NYSE:GL opened at $138.51 on Monday. The business’s fifty day moving average price is $142.07 and its 200 day moving average price is $139.00. The firm has a market capitalization of $10.89 billion, a price-to-earnings ratio of 9.84 and a beta of 0.46. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the business posted $3.14 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be issued a dividend of $0.33 per share. This is an increase from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Thursday, April 2nd. Globe Life’s dividend payout ratio is 7.67%.

Insider Transactions at Globe Life

In other Globe Life news, Director Mark A. Blinn sold 1,750 shares of Globe Life stock in a transaction on Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director owned 3,372 shares of the company’s stock, valued at $498,752.52. This trade represents a 34.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares in the company, valued at approximately $2,501,944.06. This represents a 36.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 92,186 shares of company stock worth $13,358,379. 1.97% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on GL. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Evercore set a $157.00 price objective on shares of Globe Life in a research note on Wednesday, February 18th. Piper Sandler reiterated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and a consensus target price of $171.33.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.